Genetic Factors Associated with Response to Vitamin E Treatment in NAFLD

Genetic Factors Associated with Response to Vitamin E Treatment in NAFLD

Non-alcoholic fatty liver disease (NAFLD) is becoming the predominant liver disease worldwide, and vitamin E has been clinically shown to improve histological parameters in a subset of patients. In this narrative review, we investigate whether genetic factors may help to explain why some patients sh...

Full description

Bibliographic Details
Main Authors:	Mehtap Civelek, Maren C. Podszun
Format:	Article
Language:	English
Published:	MDPI AG 2022-06-01
Series:	Antioxidants
Subjects:	vitamin E NAFLD response to treatment genetic factors
Online Access:	https://www.mdpi.com/2076-3921/11/7/1284

Similar Items

Iron metabolism mediates the relationship between Vitamin C and hepatic steatosis and fibrosis in NAFLD
by: Zhengyu Hu, et al.
Published: (2022-09-01)

Silymarin in Combination with Vitamin C, Vitamin E, Coenzyme Q10 and Selenomethionine to Improve Liver Enzymes and Blood Lipid Profile in NAFLD Patients
by: Annalisa Curcio, et al.
Published: (2020-10-01)

Effect of vitamin E on non-alcoholic fatty liver disease (NAFLD) in reversing the biochemical and radiological hepatic pathology – an interventional study
by: Divakar R., et al.
Published: (2021-12-01)

Integrins and NAFLD-associated liver diseases: clinical associations, pathophysiological mechanisms and pharmacological implications
by: Ni Yangyue, et al.
Published: (2024-09-01)

Advancements in Understanding and Treating NAFLD: A Comprehensive Review of Metabolic-Associated Fatty Liver Disease and Emerging Therapies
by: Jacob Beiriger, et al.
Published: (2023-11-01)

U-shaped association of serum vitamin A concentrations with all-cause mortality in patients with NAFLD: results from the NHANES database prospective cohort study
by: Hui Li, et al.
Published: (2024-10-01)

Treatment of NAFLD: Diet, Physical Activity, and Potential Pharmacological Options
by: Justyna Śliz, et al.
Published: (2024-07-01)

Genetic Polymorphisms and Diversity in Nonalcoholic Fatty Liver Disease (NAFLD): A Mini Review
by: Siti Aishah Sulaiman, et al.
Published: (2022-12-01)

MAFLD: How is it different from NAFLD?
by: Cameron Gofton, et al.
Published: (2023-02-01)

Communicating PNPLA3 genetic risk status for NAFLD among Mexican-origin men
by: Edgar A. Villavicencio, et al.
Published: (2023-01-01)

NAFLD and nutraceuticals: a review of completed phase III and IV clinical trials
by: Omar E. Hegazi, et al.
Published: (2023-08-01)

Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches
by: Seyedeh Kosar Mahmoudi, et al.
Published: (2024-03-01)

The Effect of Aerobic Training and Vitamin D Supplementation on Blood Pressure in Elderly Women with Nonalcoholic Fatty Liver and Vitamin D Deficiency
by: Zahra Hoseini, et al.
Published: (2019-07-01)

Therapeutic Effects of Vitamin E in Non-alcoholic Fatty Liver Disease: An Open-Labeled Clinical Trial
by: Amal jawad Fairooz, et al.
Published: (2022-12-01)

Genetics Is of the Essence to Face NAFLD
by: Marica Meroni, et al.
Published: (2021-09-01)

Study of Prevalence of Non-Alcoholic Fatty Liver Disease in Hypothyroidism and Possible Association of Hypothyroidism with NAFLD Fibrosis Score in Odisha
by: Siba Prasad Dalai, et al.
Published: (2024-07-01)

Study of Prevalence of Non-Alcoholic Fatty Liver Disease in Hypothyroidism and Possible Association of Hypothyroidism with NAFLD Fibrosis Score in Odisha
by: Siba Prasad Dalai, et al.
Published: (2024-07-01)

Vitamin C and Vitamin E in Prevention of Nonalcoholic Fatty Liver Disease (NAFLD) in Choline Deficient Diet Fed Rats
by: Lopasso Fabio P, et al.
Published: (2003-10-01)

Wheat germ oil vitamin E cytoprotective effect and its nutrigenomics signature in human hepatocyte lipotoxicity
by: Desirée Bartolini, et al.
Published: (2022-09-01)

Activation of Kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventions
by: Gao-Xin Xu, et al.
Published: (2023-05-01)

Effects of 12-weeks resistance training and vitamin E supplementation on aminotransferases, CTRP-2, and CTRP-9 levels in males with nonalcoholic fatty liver disease: a double-blind, randomized trial
by: Irfan Varmazyar, et al.
Published: (2024-09-01)

The Impact of Vitamin D in Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study in Patients with Morbid Obesity
by: Borges-Canha M, et al.
Published: (2021-02-01)

HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Alessia Di Costanzo, et al.
Published: (2020-12-01)

Sarcopenia Is an Independent Risk Factor for NAFLD in COPD: A Nationwide Survey (KNHANES 2008–2011)
by: Hong KS, et al.
Published: (2020-05-01)

Fecal Microbiota Transplantation in NAFLD Treatment
by: Ludovico Abenavoli, et al.
Published: (2022-10-01)

Insights into the role of PPARβ/δ in NAFLD
by: Tan, Nguan Soon, et al.
Published: (2018)

Metabolic Role of Autophagy in the Pathogenesis and Development of NAFLD
by: Lingxuan An, et al.
Published: (2023-01-01)

Relationships of 25-hydroxyvitamin D levels and non-alcoholic fatty liver disease in obese children: A possible strategy to promote early screening of NAFLD
by: Jeanette Irene Christiene Manoppo, et al.
Published: (2022-11-01)

Ataxia with Vitamin E Deficiency in Norway
by: Areej Elkamil, et al.
Published: (2015-01-01)

Clinical features and metabolic complications for non-alcoholic fatty liver disease (NAFLD) in youth with obesity
by: Emiliano Barbieri, et al.
Published: (2023-01-01)

Influence of genetically predicted autoimmune diseases on NAFLD
by: Min Xu, et al.
Published: (2023-09-01)

Mechanism and Progress of Natural Products in the Treatment of NAFLD-Related Fibrosis
by: Jin-Zhong Li, et al.
Published: (2023-12-01)

Triglyceride-glucose index and combined indicators: effective indicators for screening NAFLD in snoring patients
by: Yuqing Cai, et al.
Published: (2024-07-01)

Cardiovascular and Metabolic Protection by Vitamin E: A Matter of Treatment Strategy?
by: Melanie Ziegler, et al.
Published: (2020-09-01)

Circulating Ism1 Reduces the Risk of Type 2 Diabetes but not Diabetes-Associated NAFLD
by: Jiajia Wang, et al.
Published: (2022-05-01)

Alterations of liver enzymes and lipid profile in response to exhaustive eccentric exercise: vitamin D supplementation trial in overweight females with non-alcoholic fatty liver disease
by: Zahra Rahimpour, et al.
Published: (2022-08-01)

Cell-Type Resolved Insights into the Cis-Regulatory Genome of NAFLD
by: Trine V. Dam, et al.
Published: (2022-03-01)

Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future
by: Tina Reinson, et al.
Published: (2023-02-01)

Therapeutic Targets and Approaches to Manage Inflammation of NAFLD
by: Wanying Geng, et al.
Published: (2025-02-01)

Lipid Disorders in NAFLD and Chronic Kidney Disease
by: Meng Yang, et al.
Published: (2021-10-01)